Triple

T903526
Position Surface form Disambiguated ID Type / Status
Subject 2018–2020 Kivu Ebola epidemic in the Democratic Republic of the Congo E19496 entity
Predicate treatmentUsed P4714 FINISHED
Object mAb114
mAb114 is a monoclonal antibody therapy developed to treat Ebola virus disease, shown to significantly reduce mortality during recent Ebola outbreaks.
 E106453 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: mAb114 | Statement: [2018–2020 Kivu Ebola epidemic in the Democratic Republic of the Congo, treatmentUsed, mAb114]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: mAb114
Context triple: [2018–2020 Kivu Ebola epidemic in the Democratic Republic of the Congo, treatmentUsed, mAb114]
  • A. Leqembi
    Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
  • B. rVSV-ZEBOV
    rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
  • C. MAB
    MAB is a German bibliographic data format used for cataloging and exchanging library records, closely related to and historically aligned with MARC standards.
  • D. M1044
    The M1044 is a specific armored variant of the military Humvee designed for enhanced protection and tactical utility in combat environments.
  • E. Rituxan
    Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: mAb114
Triple: [2018–2020 Kivu Ebola epidemic in the Democratic Republic of the Congo, treatmentUsed, mAb114]
Generated description
mAb114 is a monoclonal antibody therapy developed to treat Ebola virus disease, shown to significantly reduce mortality during recent Ebola outbreaks.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: mAb114
Target entity description: mAb114 is a monoclonal antibody therapy developed to treat Ebola virus disease, shown to significantly reduce mortality during recent Ebola outbreaks.
  • A. Leqembi
    Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
  • B. rVSV-ZEBOV
    rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
  • C. MAB
    MAB is a German bibliographic data format used for cataloging and exchanging library records, closely related to and historically aligned with MARC standards.
  • D. M1044
    The M1044 is a specific armored variant of the military Humvee designed for enhanced protection and tactical utility in combat environments.
  • E. Rituxan
    Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a4939e889c8190ac148b3ac1a7f90b completed March 1, 2026, 7:29 p.m.
NER Named-entity recognition batch_69a4b2b9339081909af5ab231be39bb0 completed March 1, 2026, 9:42 p.m.
NED1 Entity disambiguation (via context triple) batch_69a7c736bb6c8190a9cad1ef536be785 completed March 4, 2026, 5:46 a.m.
NEDg Description generation batch_69a7c7a5f03c81908bd3ed9eb3710141 completed March 4, 2026, 5:48 a.m.
NED2 Entity disambiguation (via description) batch_69a7c888cd98819082dc39739d14dc67 completed March 4, 2026, 5:52 a.m.
Created at: March 1, 2026, 7:39 p.m.